XNYS
TSLX
Market cap1.32bUSD
Jul 22, Last price
16.77USD
1D
-2.10%
1Q
-9.60%
Jan 2017
-10.22%
IPO
4.16%
Name
Sixth Street Specialty Lending Inc
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sixth Street Specialty Lending, Inc. (TSLX) functions as a specialized Business Development Company. It provides a wide array of financing solutions, including various forms of debt such as senior secured loans (encompassing first-lien, second-lien, and unitranche facilities), unsecured loans, and mezzanine debt. The firm also strategically allocates capital to corporate bonds, equity securities, structured products, non-control structured equity, and common equity, frequently engaging in co-investments. These financial commitments primarily aim to facilitate corporate endeavors like organic expansion, strategic acquisitions, market or product diversification, restructuring initiatives, recapitalizations, and refinancing. Its investment focus covers a broad range of sectors, including business services, software and technology, healthcare, energy, consumer and retail, manufacturing, industrials, royalty-generating enterprises, education, and specialty finance. The company primarily targets middle-market companies, with a strong emphasis on those situated within the United States. Prospective portfolio companies typically exhibit an enterprise value between $50 million and more than $1 billion, alongside EBITDA figures ranging from $10 million to $250 million. Individual transaction sizes generally range from $15 million to $350 million. Sixth Street Specialty Lending is adept at investing across the entire capital structure, possesses the capacity to arrange syndicated transactions totaling up to $500 million, and can maintain significant ownership stakes within its credit exposures.
IPO date
Mar 21, 2014
Employees
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||